Development of new endpoints and analysis methods for clinical trials in COVID-19 patients
Not Applicable
- Conditions
- COVID-19
- Registration Number
- JPRN-UMIN000051337
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1063
Inclusion Criteria
Not provided
Exclusion Criteria
Patients enrolled and randomized in the ACTT-1 trial
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method